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ABSTRACT
Humoral immune response was assessed in
60 children with acute post-streptococcal glomeru-
lonephritis in parallel with IS children with only
skin streptococcal infection and 20normal
children.
B-lymphocytes as assessed by EAC rosettes
estimation was significantly elevated in patients.
Markedly high anti-DNase B antibody titres were
demonstrated in patients and to a less extent in
skin infection controls,a  compared to normal
controls.
C3 levels were decreased in all the patients and
C4 levels were decreased in 76%. The levels
returned to normal 2 months later. C3 and C4
levels were normal in skin infection and normal
controls.
Serum IgG, IgM, IgA were normal in patients
and Rheumatoid factor was positive in only 24%o f
patients, all of whom had a low positive titre.
These studies indicate marked humoral immune
response to streptococcal infection in patients with
APSGN. IgG anti-IgG immune complex did not
play a sign&ant role in our patients.
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Acute post streptococcal glomerulo-
nephritis (APSGN) is a well recognised
sequele to nephritogenic streptococcal(1-5)
infection. It is generally regarded as an
immune complex disease (6-8) but the
nature of the antigen is not known.The
antigen has been variously reported as
being in the streptococcal cell wall, pro-
toplasmic membrane or extra cellular
product (7,8). Some reports mention that
alteration of the immunoglobulin (Ig)
(9,10) or glomerular basement membrane
(7) may occur as a result of streptococcal
infection so that the altered IgG or glo-
merular basement membrane acts as an
antigen.
Apart from the nature of the antigen,
the nature of the antibody response in the
h st is of crucial importance in the for-
mation of pathogenic immune com-
plexes (11).
There have been very few reports in
India regarding the immune response in
children with APSGN. The present study
aims at assessing the humoral immune
response in APSGN in comparison to
skin infection and normal controls.
Material and Methods
60 patients admitted at the Institute
for C ild Health, Madras, with the clinical
picture of APSGN and 15 children
(siblings of patients) with pyoderma but
no nephritiswere studied. 20 other
children with no skin or pharyngeal
infection and normal urinary findings
served as normal controls. The ages
of the patient and controls ranged from
2 to 12 years, and they came from the
same socio-economic strata.
The clinical criteria for APSGN was:
1. Acute onset of oliguria, edema
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2.
3.
4.
with proteinuria and gross or
microscopic hematuria.
Hypertension with or without
other features, as cardiac failure,
hypertensive encephalopathy or
acute renal failure.
No history of previous renal disease.
History of recent skin or throat
infection.
Patients with features of Nephrotic
syndrome such as massive albuminuria,
hypoalbuminemia and hypercholesterole-
mia were excluded.
Blood samples
On admission, blood was collected
for anti-DNase-B, ASO titres, C3, C4,
immunoglobulins and rheumatoid factor
estimations.Subsequently samples were
collected from patients 2 months later.
Storage of sera was at –20°C in small
aliquots.
Methods Significant (+) p< .001.
1. EAC Rosettes: C3 receptor lym-
phocytes were determined using
the technique as outlined by Bianco
et al. (12).
2. Anti streptococcal antibodies anti-
DNase-B and ASO titres were esti-
mated by the micro technique
determination( 13).
3. Complement factors C3 and C4,
immunoglobulins IgG, IgM, IgA
levels were determined by the
single radial immunodiffusion
method of Mancini et al. (14) using
monospecific antisera(immuno
diagnostics).
4. Rheumatoid factor was assessed
by the Rosewaler test.
Results
Surface markers for E-lymphocyte
The results are summarised in Table 1.
Patients with APSGN had significantly
elevated EAC rosettes as compared to the
skin infection and normal controls. The
proportion of EAC rosettes was nearly
32% in patients as compared to 18.9%
and 19.6% in the other 2 groups.
TABLE I – Proportion of B-lymphocytes (EAC
rosettes) in APSGN and controls
Group No.
B-lymphocytes
mean, SD and
range
AGN 30 31.9 ± 7.4*
(20–48)
Normal control 20 18.9 ± 4.19
(10–28)
Skin infection controls 5 19.6 ± 5.5
(14–28)
Anti-DNase-B and ASO titres
The mean titre for normal controls
was 401.66 with a range of 75 to 800.
The levels in patients and skin infec-
tion controls were significantly higher
than that in normal controls. 100% of
patients had elevated anti-DNase-B levels
compared to 87 % in skin infection controls
and 0% in normal controls.
The titres were as high as 76,800 in 10%
of patients (Table II).
The mean titre of ASO was not signi-
ficantly increased in patients or skin in-
fection controls.Only 3 patients and 2
skin infection controls had elevated ASO
titres.
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Serum immunoglobulins and complement
factors C3 and C4
The levels of IgG, IgM and IgA were
within normal limits in patients, skin
infection and normal controls. C3 levels
were decreased in all the patients during
the acutephase (p<.001). C4 levels
were low in 46 patients (76.6%) and nor-
mal levels in 14 patients. The levels of
C3 and C4 in skin infection and normal
controls were within the normal range.
C3 a d C4 returned to normal levels when
the sera of 25 patients were tested 2
months after onset of disease (Tabl  III).
Rheumatoid factor
Differential agglutination titres (DAT)
of less than 1/8 was taken as negative.
76% of the patients were negative for
rheumatoid factor. The remaining 24%
were positive in the acute phase. 10 had
titres of 1/16 and 4 had titres of 1/32.
TABLE II – Anti-DNase-B and SAO titre in APSGN and controls
ASO Anti-DNase-B
Group No. Mean,
AGN 51 210 ± 206
(85–1360)
9080.39 ± 14860.3*
(1200–76,800)
Contact (skin infection) controls,15 302 ± 365
(85–1360)
2886.6 ± 1626.94**
(300–4800)
Normal controls 15 134 ± 121
(85–340)
SD and range
401.66 ± 316.01
(75–800)
*Highly significant P < .003 when compared to normal controls.
**Highly significant P < .001 when compared to normal controls.
TABLE III – C3, C4 levels in APSGN and controls
Acute phase 2 months later
(25 patients)
Group No. C3 C4 C3 C4
AGN 60 35.8*  ± 15.3 15.9** ± 7.9 61.8 ± 20.6 34.7 ± 14.1
Skin infection
controls 14 108.3 ± 21.4 26.8 ± 6.7 – –
Normal controls 14 103.2±40.9 28.4±8 – –
*P < .001 significant **P< .001 significant.
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Discussion
Proportions of B-lymphocytes, as esti-
mated by EAC rosettes were significantly
higher in patients with APSGN as com-
pared to skin infection and normal
controls. B-lymphocytes estimated by
fluorescein-labelled aggregates for cells
bearing FC receptors were found to be
elevated in children with APSGN in a
study by Williams et al. (15). They also
reported that EAC rosettes were reduced
in the same patients which they attributed
to the saturation of EAC receptors by
complexes or other factors present in the
sera.
Our data show markedly elevated anti-
DNase-B titres in patients with APSGN.
There was also good response in skin
infection controls but not to the extent as
in patients. The strikingly high anti-
body titres in patients suggests that attack
rates are perhaps related to the magnitude
of immune response (16,17). Hyperim-
mune anti-DNase-B responses in patients
with APSGN have been reported after
pyoderma (3,16,17,19). Dillon reported
that streptococcal immune response in
patients with AGN is significantly greater
than in comparable groups of infected
controls (16). The magnitude of the
immune response in streptococcal infec-
tions may be related to genetic factors in
the host, variables such as chronicity of
infections and serotypes of infecting
strains( 17).
In our study only 3 patients and 2
skin infection controls had elevated ASO
titres. Therefore, anti-DNase-B esti-
mation is superior to the ASO titres as an
indicator of streptococcal skin infection.
This has been attributed to the fact that
skin lipids may inhibit streptolysin-O(20).
C3 levels were decreased during the
acute phase in all our patients, C4 was
decreased in 46 patients and normal in 14.
Both returned to normal 2 months later.
Other investigators have demonstrated
decreased levels of C3 in patients with
APSGN (6,21). This suggests that the
low C3 in APSGN occurred as a result of
activation of the classical pathway.
Recent reports have shown that C19 and
C4 levels were normal and C3 was lowered
due to activation of alternate complement
pathway (5,22,23).Onyewottu et al. (5)
reported increased levels of immune
complexes and low C3 levels in APSGN
but C4 was normal. It was postulated
tha  C4 levels could be normal, because
of increased synthesis of C4 so that low
levels are detected only during early
stages of nephritis. In our patients the
mean duration of illness before hospi-
talis tion was 4 days, hence C4 ould be
es mated early in the course of the disease.
Our data showed that C3 and C4 levels
were normal in skin infection and normal
controls.
IgA, IgG, and IgM levels were normal
in patients, skin infection controls and
normal controls. Rheumatoid factor was
positive in only 24% of our patients.10
of them had DAT of 1/16 and 4 had 1/32,
Mohammed et al. (4) have made similar
obs rvations in their study.
Bernardo-Rodriguezet al. (9) and
MCIntosh(10) reported increased levels of
serum IgG in majority of their patients
w th elevated rheumatoid factor in a large
percentage of patients.
The low percentage of positive rheu-
matoid factor and low levels of positive
titres indicate that IgG anti-IgG immune
complex may not play a significant role
in the pathogenesis of the disease in our
patien s.
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